Alliance for Pandemic Preparedness

April 3, 2020

Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia.

Category:

Topic:

  • Pizzorno et al provide new insights on SARS-CoV-2 biology, evidence on the antiviral efficacy of remdesivir, and the therapeutic potential of a virus-detected and a host-direct drug combination (e.g. remdesivir-diltiazem combination) as a probable option to respond to the current unmet medical need imposed by COVID-19. 

Pizzorno et al. (Mar 31, 2020). Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Pre-print downloaded Apr 3 from https://doi.org/10.1101/2020.03.31.017889